Activity value 61china Supplier,Last transaction date:
2023-11-08
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for lianyungang runzhong pharmaceutical from 2022 to 2023.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2023, the company has completed 1 transactions, with a transaction quantity of 0.2 and a transaction weight of 0.1.
YearTransactionsQuantityWeight
2022000
202310.20.1
Bill of lading data
<
1/5
>
Trade date
2021/08/23
B/L No.
——
Suppliers
lianyungang runzhong pharmaceutical
Buyers
helsinnpharm cia ltd.
4ооо биокад
russiabuyer,they trade on 2014-03-28
112.50%
>
5ао фармасинтез
russiasupplier,they trade on 2023-11-08
112.50%
>
+View All
Products
Total 1
ProductsTransactionsPerDetail
consumable materials for quality inspection 1100%>
Hscode rank
Total 7
HSCode NameTransactionsPerDetail
HS 29372900001100%>
Trading Area
Total 3
AreaTransactionsPerDetail
ecuador337.50%>
russia337.50%>
india225.00%>
Port statistics
Total 1
Port NameTransactionsPerDetail
beijing nanyuan112.50%>
lianyungang runzhong pharmaceutical is china Supplier,
and primarily engages in the import and export business of products such as consumable materials for quality inspection.
According to the 52wmb.com global trade database, as of 2023-11-08, the company has completed 8 international trades,
with its main trading regions covering ecuador,russia,india etc.
The core products include HS2937290000 etc,
often transported via beijing nanyuan etc,
and its main trading partners are fresenius kabi oncology plc,helsinnpharm cia ltd.,ginsberg ecuador s.a..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on lianyungang runzhong pharmaceutical is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.